Mishra Alita, Younossi Zobair M
Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA.
Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA ; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
J Clin Exp Hepatol. 2012 Jun;2(2):135-44. doi: 10.1016/S0973-6883(12)60102-9. Epub 2012 Jul 21.
Non-alcoholic fatty liver disease (NAFLD) is an important cause of liver disease burden across the world. By definition, although the histopathologic features of NAFLD are identical to that of alcoholic liver disease, its diagnosis requires absence of significant alcohol use and absence of other causes of chronic liver disease. We now know that NAFLD is not simply a disease of the Western world. It is manifested across the world, in varying rates, across gender, across varying ethnicities, and in its association with other host factors. In this review article, the definition of NAFLD, its spectrum, ranging from mild steatosis to hepatocellular injury and inflammation defined as non-alcoholic steatohepatitis (NASH) is discussed. Mild steatosis is generally a stable disease whereas NASH can be progressive. Based on current published literature, current incidence and prevalence of NAFLD and NASH are discussed. It is also accepted that these processes will continue to increase in prevalence with the rise of obesity, type II diabetes, and associated metabolic syndrome. Some of the risk factors have been well-established and are discussed. In addition, this review also presents emerging associations with other risk factors for NAFLD. Natural history of NAFLD is variable depending upon the histologic subtypes and other underlying comorbidities and is discussed in this review as well.
非酒精性脂肪性肝病(NAFLD)是全球肝脏疾病负担的一个重要原因。根据定义,尽管NAFLD的组织病理学特征与酒精性肝病相同,但其诊断需要排除大量饮酒以及其他慢性肝病病因。我们现在知道,NAFLD并非仅仅是西方世界的疾病。它在全球范围内均有表现,在不同性别、不同种族中发病率各异,且与其他宿主因素相关。在这篇综述文章中,我们将讨论NAFLD的定义、其范围,从轻度脂肪变性到肝细胞损伤以及被定义为非酒精性脂肪性肝炎(NASH)的炎症。轻度脂肪变性通常是一种稳定的疾病,而NASH可能会进展。基于当前已发表的文献,我们将讨论NAFLD和NASH的当前发病率及患病率。人们也普遍认为,随着肥胖症、2型糖尿病以及相关代谢综合征发病率的上升,这些疾病的患病率也将持续增加。一些风险因素已经明确并在文中进行了讨论。此外,本综述还介绍了与NAFLD其他风险因素的新关联。NAFLD的自然病程因组织学亚型和其他潜在合并症而异,本文也将对此进行讨论。